Grand Rapids · Seed–Series A · 13 people tracked
Investment thesis
Genesis Innovation Group operates as a builder and investor in the medical device space, partnering directly with entrepreneurs and inventors to develop technology from concept to market. It combines a full platform of development services—ideation and engineering, governance and fundraising, manufacturing, regulatory and quality, and commercialization—with hands-on investment. The group leverages a network of surgeons, researchers, manufacturers, and distributors to accelerate development and expand market reach. It has launched subsidiaries such as Capitan Orthopedics, reflecting a venture-studio approach where the team is directly involved in creating and scaling companies rather than acting solely as a passive capital provider.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from the firm's website & curated & public directoriesFounder mafia
2 people who came through Genesis Innovation Group went on to found or lead other companies.
What they invest in
from 5 of 10 portfolio companiesHealthtech ×4Hardware ×3Medical Devices ×3Biotech ×2
HQs:United States×5
Investments · 10 tracked
founders shown can be your intro pathShoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis.
HardwareHealthtechMedical DevicesNorthern California, US
Robert Ball(CEO & Executive Chairman)Matthew Ahearn(Chief Operating Officer)Jeff Points(Executive Officer)David Blue(Executive Officer)Don Running(Manager and Chief Executive Officer)Jeff Ondrla(Chief Technology Officer)
Co-investorsAPERTURE Venture PartnersArboretum VenturesGlobal BrainInvest MichiganLightstone VenturesUS Venture Partners+2 more
Capitan Orthopedics develops SupraSpacer, a minimally invasive shoulder implant that acts as a spacer to restore joint alignment for patients with irreparable rotator cuff tears.
HardwareHealthtechMedical DevicesGrand Rapids, US
Chance Leonard(Chief Executive Officer)
BoardRobert Sean Churchill(Director)Jeff Ondrla(Director)Chance W. Leonard(Executive Officer, Director)inR. Sean Churchill(Board Member / Surgeon Design Team)Rich Mazzola(Co-Founder & CFO of Project MedTech)
Developer of biointegrative soft tissue regeneration solutions for orthopedic injuries; acquired by Zimmer Biomet in 2023.
BiotechVienna, US
Jeffrey Conroy(Chief Executive Officer)Michael Francis(Director)Tim Meyers(Director)Michael O'Kane(Director)
BoardRob Ball(Director)
HealthtechGrand Rapids, US
Ryan Roeder(Executive Officer, Director)
BoardMatt Ahearn(Director)Brian McCollum(Director)Ben Olds(Director)Matt Milanowski(Director)Steven Foster(Director)
Co-investorsWMU Biosciences Research & Commercialization Center
Company that grew with strategy development and investment from Genesis.
A monolithic hydroxyapatite-impregnated PEEK spinal fusion device with porous regions for load bearing and healing.
Platform integrating AI scanning, patient health history, and expert guidance to create personalized back-pain care plans.
Nanochon develops Chondrograft, a 3D-printed, off-the-shelf orthopedic implant that is press-fit into damaged knee cartilage to support the body's natural tissue healing.
BiotechHardwareHealthtechMedical DevicesWashington, US
Benjamin Holmes(Executive Officer, Director)Nathan Castro(Executive Officer, Director)Ben Holmes(CEO & Co-founder)
BoardNick Pachuda(Director)Kurt Jacobus(Director)Robert Creeden(Director)
Co-investorsAsimov VenturesWealthing VC ClubTEDCO
Custom software development platform using AI and ML for healthcare and digital health, transforming medical imaging and patient engagement.
A shoulder joint spacer implant that restores anatomical spacing and joint alignment when the rotator cuff is torn.
Exits · 3
IPOs and acquisitions across the tracked portfolioShoulder InnovationsNYSE: SIEmbodyacq. by ExtraOrthoImascap SASacq. by Wright Medical
Portfolio news
latest coverage across their companiesCapitan Orthopedics · gsmedtech.com · Aug 24, 2026
Shoulder Innovations · investing.com · Jun 29, 2026
Nanochon · voxelmatters.com · Feb 16, 2026
HAPPE Spine · finance.yahoo.com · Nov 13, 2025
Frequently asked questions
- How many investments has Genesis Innovation Group made?
- Genesis Innovation Group has 10 tracked investments, 2 of which have exited via acquisition or IPO.
- What stage does Genesis Innovation Group invest at?
- Genesis Innovation Group invests at the Seed, Series A stages.
- What sectors does Genesis Innovation Group focus on?
- Genesis Innovation Group focuses on Digital Health, Healthtech, Medical Devices.
- Where is Genesis Innovation Group located?
- Genesis Innovation Group is headquartered in Grand Rapids, US.
- Who does Genesis Innovation Group co-invest with?
- Genesis Innovation Group most often shares deals with WMU Biosciences Research & Commercialization Center, Arboretum Ventures, Global Brain, among 10 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.






.jpeg)
